PCI Biotech - Company & Market Research Reports

PCI Biotech is a biopharmaceutical company that produces therapies to fight against cancer through creating photochemical internalisation (PCI) technology platform. This platform is divided into 3 different segments such as: fimaCHEM, fimaVACC and fimaNAc. FimaCHEM is the company's main programme and it focuses on studying bile duct cancer. The fimaVACC studies the cytotoxic effect of therapeutic cancer vaccines. The fimaNAc is used to provide the delivery of nucleic acids: mRNA and siRNA. PCI Biotech was founded in 2000 and is based in Lysaker, Norway. They are a subsidiary of PCI Biotech Holding ASA.

Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018

  • Report
  • 385 Pages
From
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016 - Product Thumbnail Image

Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016

  • Drug Pipelines
  • 722 Pages
From
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016 - Product Thumbnail Image

Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016

  • Drug Pipelines
  • 713 Pages
From
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015 - Product Thumbnail Image

Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

  • Drug Pipelines
  • 515 Pages
From
Biotherapeutics: Novel Formulation and Delivery Approaches (Focus on Antibodies and Proteins) - Product Thumbnail Image

Biotherapeutics: Novel Formulation and Delivery Approaches (Focus on Antibodies and Proteins)

  • Report
  • 301 Pages
From
Melanoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Melanoma - Pipeline Review, H1 2018

  • Drug Pipelines
  • 2011 Pages
From
PCI Biotech AS - Product Pipeline Review - 2015 - Product Thumbnail Image

PCI Biotech AS - Product Pipeline Review - 2015

  • Company Profile
  • 34 Pages
From
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2018 - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 853 Pages
From
Cellular Tumor Antigen P53 (Tumor Suppressor P53 or Antigen NY-CO-13) - Pipeline Review, H1 2016 - Product Thumbnail Image

Cellular Tumor Antigen P53 (Tumor Suppressor P53 or Antigen NY-CO-13) - Pipeline Review, H1 2016

  • Drug Pipelines
  • 119 Pages
From
The Pharmaceutical Market: Norway - Product Thumbnail Image

The Pharmaceutical Market: Norway

  • Report
  • 67 Pages
From
PCI Biotech Holding ASA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

PCI Biotech Holding ASA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • 50 Pages
From
PCI Biotech Holding ASA (PCIB) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

PCI Biotech Holding ASA (PCIB) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • 25 Pages
From
PCI Biotech Holding ASA Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report - Product Thumbnail Image

PCI Biotech Holding ASA Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

  • Financial Report
  • 35 Pages
From
PCI Biotech Holding ASA - Product Thumbnail Image

PCI Biotech Holding ASA

  • Company Profile
  • 75 Pages
Q2 2018 Earnings Call - PCI Biotech Holding ASA, - Earnings Transcript - Product Thumbnail Image

Q2 2018 Earnings Call - PCI Biotech Holding ASA, - Earnings Transcript

  • Earnings Transcript
Q1 2018 Earnings Call - PCI Biotech Holding ASA, - Earnings Transcript - Product Thumbnail Image

Q1 2018 Earnings Call - PCI Biotech Holding ASA, - Earnings Transcript

  • Earnings Transcript
Q4 2017 Earnings Call - PCI Biotech Holding ASA, - Earnings Transcript - Product Thumbnail Image

Q4 2017 Earnings Call - PCI Biotech Holding ASA, - Earnings Transcript

  • Earnings Transcript
PCI Biotech Holding ASA Strategic Analysis Review - PCI Biotech Holding ASA SWOT, Outlook, Operations and Financial Profile - Product Thumbnail Image

PCI Biotech Holding ASA Strategic Analysis Review - PCI Biotech Holding ASA SWOT, Outlook, Operations and Financial Profile

  • Company Profile
  • 30 Pages
From
Q2 2017 Earnings Call - PCI Biotech Holding ASA, - Earnings Transcript - Product Thumbnail Image

Q2 2017 Earnings Call - PCI Biotech Holding ASA, - Earnings Transcript

  • Earnings Transcript
Q1 2017 Earnings Call - PCI Biotech Holding ASA, - Earnings Transcript - Product Thumbnail Image

Q1 2017 Earnings Call - PCI Biotech Holding ASA, - Earnings Transcript

  • Earnings Transcript
Loading Indicator
adroll